Search the web
Welcome, Guest
[Sign Out, My Account]
Morningstar_Inc.

Friday, August 29 2014 10:17pm ET - U.S. Markets Closed.
Industry Center - Drugs - Generic
Industry Center > Drugs - Generic
More On This Industry
Summary
·News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
Top Industries
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Diversified Utilities
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
·Tobacco Products, Other
Complete Industry List...
Morningstar Inc.
In-depth Company Dossier Reports on over 7,500 publicly traded U.S. companies. Click here for your free report.
  
Industry Market Summary
Drugs - Generic
Composite Value: 1241.7
Today's Change: +0.05%
S&P 500: +0.33%
chart for
[Drugs - Generic (^YHOh785)]
Drugs - Generic News
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Galectin Therapeutics, Inc. (GALT) To Contact The Firm
1 hour, 2 minutes ago (PR Newswire)
NEW YORK, Aug. 29, 2014 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Galectin Therapeutics, Inc. ("Galectin" or the "Company") (GALT) of the September 29, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against Galectin and certain executives. The complaint alleges that the Company and its executives violated federal securities laws with respect to its disclosures concerning its business, operations, and prospects. Specifically, the action alleges that during the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Galectin paid stock promoters to distribute positive but false reports about the Company's prospects;
Mylan's ANDA for Three Times Per Week Generic Copaxone® 40 mg/mL Accepted for Filing by FDA - (PR Newswire)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT - (PR Newswire)
More News on Drugs - Generic: Latest News,
Industry Top Performers
Intraday Price Performance% ChangeMarket Cap
Agile Therapeutics, Inc. [AGRX] +9.61% $143.2 M
IPSEN [IPN.PA] +7.91% -$1000.0 K
Aquinox Pharmaceuticals, Inc. [AQXP] +7.46% $81.7 M
Parnell Pharmaceuticals Holding [PARN] +7.37% $46.1 M
SCYNEXIS, Inc. [SCYX] +6.31% $55.3 M
More Top Intraday Price Performers...
Market Capitalization% ChangeMarket Cap
SUN PHARMACE [SUNPHARMA.BO] -0.84% $1773.5 B
LUPIN LTD [LUPIN.BO] -0.05% $577.1 B
LUPIN LIMITED [LUPIN.NS] -0.33% $576.3 B
DR.REDDYS L [DRREDDY.BO] +0.96% $502.7 B
DR REDDY'S LAB DEPO SETT. [DRREDDY.NS] +0.86% $502.1 B
More Top Companies by Market Cap...
More Top Performers: by Valuation, by Growth, by Financial Strength
Industry Calendar
Upcoming Events
Date Co Event
08/29/14 2877.HK Interim 2014 China Shineway Pharmaceutical Group Ltd Earnings Release
08/29/14 IPN.PA Half Year 2014 Ipsen SA Earnings Release
09/10/14 APH.L Half Year 2014 Alliance Pharma PLC Earnings Release
More Upcoming Events...
Recent Events
Date Co Event
08/14/14 AGRX Agile Therapeutics, Inc. upside earnings surprise (+24.32%)
08/14/14 GUD.TO KNIGHT THERAPEUTICS INC upside earnings surprise (+200.00%)
08/14/14 FLXN Flexion Therapeutics, Inc. coverage initiated by Summer Street Research
More Recent Events...
Sponsor Results
9 Best Stocks to Own Now
Here's a list of recommendations that several top analysts agree on
www.dailytradealert.com
Pharmaceutical Institute
High-impact training solutions for pharma and biotech
www.pharmainstitute.com
Protein Biomarkers
Unbiased biomarker discovery >1000 proteins assayed per sample
www.somalogic.com
(What's This?)
  
Locate Industry by Company
Enter Symbol:
Industry Statistics
Market Capitalization:7,076B
Price / Earnings:66.8
Price / Book:-18.9
Net Profit Margin (mrq):6.8%
Price To Free Cash Flow (mrq):-71.9
Return on Equity:24.6%
Total Debt / Equity:48.7
Dividend Yield:0.6%
View Industry Browser
Community Spotlight
Most Active Boards
Board Popularity
SRLS
GNVC
WPI
Unusually Active Boards
Board Variance
SRLS
GNVC
WPI

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drugs - Generic Headlines
More Finance RSS Feeds


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?